Yazar "Muhammet Uslug" seçeneğine göre listele

Listeleniyor 1 - 2 / 2
  • Küçük Resim
    Öğe
    Serodiagnosis of hydatidosis in sheep and goats in Siirt province, Türkiye, and an alternative approach to the interpretation of serology results
    (Elsevier BV, 2024-02) Burcak Aslan Celik; Muhammed Ahmed Selcuk; Figen Celik; Ozgur Yasar Celik; Muhammet Uslug; Afra Sena Tekin; Kerem Ercan; Sami Simsek
    Cystic echinococcosis (CE) is one of the most important zoonotic diseases worldwide, affecting both humans and animals, caused by Echinococcus granulosus sensu lato. The diagnosis of CE is based on the evaluation of imaging, serological, molecular and clinical findings. The aim of this study was to develop a diagnostic method that can be used for herd-based diagnosis of CE, which is commonly observed in sheep and goats, and to prevent economic losses by treating positive animals. Antigen B rich partially purified cyst fluid antigen was prepared from a sheep liver hydatid cyst. To determine the sensitivity and specificity of the antigen B-rich partially purified cyst fluid antigen, a Western blot test was first performed using hydatid cyst positive sera from 24 sheep and 20 goats collected from the abattoir and sera from 27 newborn lambs and 23 goat kids as negative controls. Subsequently, 500 sera were collected from 250 sheep and 250 goats from Siirt province and its districts. The strongest band was at 72 kDa, followed by bands at 55 kDa and 28 kDa in SDS-PAGE. According to the 43 kDa band as reference the sensitivity was 62.5 %. and specificity was 96.2 % in sheep. Besides, of the 250 sheep sera collected from the field, and the seroprevalence was 52.80 %. In goats, the sensitivity of WB was 55 % and the specificity was 86.9 %. On the other hand, the seroprevalence was 44.4 % in goats. In conclusion, the production of antigens that are easy to prepare, inexpensive and can be used in field screening for CE will be important in terms of treating positive sheep (even when CE and other helminth parasites are present together) with albendazole and preventing economic losses.
  • Küçük Resim
    Öğe
    Serological diagnosis and post-treatment monitoring of Echinococcus granulosus in experimentally infected dogs using crude and recombinant fibronectin antigens
    (Elsevier BV, 2025-07) Figen Celik; Muhammed Ahmed Selcuk; Muhammet Uslug; Sami Simsek
    Echinococcus granulosus is a zoonotic helminth responsible for cystic echinococcosis, a significant public health concern. The diagnosis of E. granulosus infections in definitive hosts, such as dogs, is challenging due to the absence of clinical signs. This study aimed to evaluate the diagnostic performance of crude (EgSCA) and recombinant (rEgFN162) antigens for the detection of E. granulosus infection in dogs using ELISA and Western blot assays. Additionally, it sought to identify the most suitable antigen and method for population-based screening and post-treatment monitoring. Adult E. granulosus parasites were collected from experimentally infected dogs using arecoline hydrobromide purgation. Soluble crude antigen (EgSCA) was prepared through freeze-thaw cycles, sonication, and filtration, while recombinant fibronectin protein (rEgFN162) was obtained via gene cloning, expression, and purification in E. coli. The antigenic properties of EgSCA and rEgFN162 were analyzed by SDS-PAGE and Western blot. ELISA assays were performed to assess IgG and IgM responses in experimentally infected and treated dogs. Based on IgG ELISA results, EgSCA showed a sensitivity of 96.66 % and specificity of 66.66 %, while rEgFN162 demonstrated a sensitivity of 76.66 % and specificity of 46.66 %. In Western blot analysis, EgSCA achieved a sensitivity of 90 % and specificity of 83.33 %, whereas rEgFN162 showed 66.66 % sensitivity and 73.33 % specificity. The recombinant antigen showed a higher ability to differentiate E. granulosus infections from other helminth infections. The findings suggest that rEgFN162 is a promising candidate for the serodiagnosis of E. granulosus in dogs, with potential applications in epidemiological studies and post-treatment follow-up. Further validation with larger sample sizes is needed to confirm its diagnostic accuracy in natural infections.